45 h. ago Obesity experts point to flaw in Trump’s weight loss drug deal despite price cuts and expanded eligibility

Studies have shown that many patients regain weight after stopping the medication

Economics

51 h. ago ‘Dozy Don’ allegations reappear after president closes eyes during Dr. Oz speech

President photographed appearing to doze during announcement of price cuts for weight loss drugs – which tackle obesity and aid sleep

Politics

3 d. ago Trump unveils deal to expand coverage and lower costs on obesity drugs

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy

Economics

4 d. ago Novo Nordisk cuts sales and profits guidance amid obesity drug competition

The boss of the Wegovy firm linked its reduced guidance to the market for weight-loss treatments being ‘more competitive than ever’.

Economics

1 week ago Novo Nordisk bids $9bn for obesity drug maker Metsera in challenge to Pfizer

US biotech viewed as lucrative target partly because of its promising pipeline of weight-loss drugsNovo Nordisk has launched a surprise $9bn (£6.9bn) offer for the US obesity-focused biotech firm Metsera that could gazump an existing bid from Pfizer as the pharmaceutical giants fight for dominance in the weight-loss market.The bid comes weeks after Metsera agreed to a $7.3bn takeover from the US group Pfizer. Denmark’s Novo Nordisk, which owns the weight-loss drugs Ozempic and Wegovy, lost out in a competitive auction processin September. Continue reading...

Events

1 week ago The US obesity rate is declining thanks to weight loss drugs, survey finds

There are now 7.6 million fewer American adults living with obesity

Events

3 w. ago Novo Nordisk’s ‘lottery ticket’: can obesity drugs help treat Alzheimer’s?

Results are due soon from two studies using semaglutide to treat thousands of people with the disease

Events